Paeoniflorin-6′-o-benzene sulfonate (CP-25) improves vasculitis through inhibitingIL-17A/JAK/STAT3signaling pathway in endothelial cells ofHFD CIArats
Paeoniflorin-6′-o-benzene sulfonate (CP-25) improves vasculitis through inhibitingIL-17A/JAK/STAT3signaling pathway in endothelial cells ofHFD CIArats
复制标题
DOI：
10.1002/ptr.6870
复制
发表时间：
2020-10-02
影响因子：
7.2
通讯作者：
Wei, Wei
中科院分区：
文献类型：
--
作者：
Cai, Xiao-Yu;Ge, Jing-Ru;Wei, Wei
Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects not only joints but also multiple organ systems including cardiovascular system. Endothelial dysfunction plays an important role in cardiovascular diseases (CVD). In RA, endothelial dysfunction exists at both the macrovascular and the microvascular levels, which is a precursor to vasculitis. This study aimed to investigate the pathogenesis of vasculitis and the therapeutic effect of CP-25 on vasculitis in high-fat diet (HFD) collagen-induced arthritis (CIA) rats. Experimental groups were divided into normal group, HFD group, CIA group, HFD CIA group, CP-25 group and MTX group. In vitro, IL-17A was used to stimulate human umbilical vein endothelial cells (HUVECs), and then CP-25 was used to intervene. Results showed that CP-25 reduced global scoring (GS), arthritis index (AI), and swollen joint count (SJC) scores, improved histopathological score, reduced T cells percentage, and decreased IL-17A and ICAM-1 levels. Besides, CP-25 reduced the expression of p-STAT3 to normal levels in vascular of HFD CIA rats. In vitro, IL-17A promoted the expression of p-JAK1, p-JAK2, p-JAK3, pSTAT3, and ICAM-1, and CP-25 inhibited the expression of p-JAK1, p-JAK2, p-JAK3, p-STAT3, and ICAM-1. In conclusion, CP-25 might inhibit endothelial cell activation through inhibiting IL-17A/JAK/STAT3 signaling pathway, which improves vasculitis in HFD CIA rats.
